NKG2D is an activating immune-receptor expressed on NK-cells able to bind MHC class I-related proteins (MICA and MICB) and ULBP proteins poorly expressed by normal cells, but frequently upregulated in tumor cells (20–22). This evidence concerns the gene KLRK1 and neoplasm.